LSTA Earnings

Quarterly EPS
$-0.59
Q3 2024
$-0.55
Q4 2024
$-0.55
Q1 2025
$-0.54
Q2 2025
$-0.49
Q3 2025
$-0.34
Q4 2025
$-0.50
Q1 2026
$-0.32
Q2 2026
Latest RevenueN/A
Latest Net Income-2929000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.320-2929000-100.0%+40.7%
Q1 2026-$0.500-4489000—+9.1%
Q4 2025-$0.34100.0K-2954000-90.0%+38.2%
Q3 2025-$0.490-4249000—+16.9%
Q2 2025-$0.5470.0K-4659000—+11.5%
Q1 2025-$0.550-4724000—+15.4%
Q4 2024-$0.551.0M-4610000—+16.7%
Q3 2024-$0.590-4930000—+9.2%
Q2 2024-$0.610-5044000——
Q1 2024-$0.650-5401000——
Q4 2023-$0.660-5365000——
Q3 2023-$0.650-5261000——
Lisata Therapeutics (LSTA) — Earnings